↓ Skip to main content

Vitamin A supplementation for cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vitamin A supplementation for cystic fibrosis
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd006751.pub2
Pubmed ID
Authors

O'Neil, Catherine M, Shevill, Elizabeth, Chang, Anne B, Catherine M O'Neil, Elizabeth Shevill, Anne B Chang

Abstract

People with cystic fibrosis and pancreatic insufficiency are at risk of fat soluble vitamin deficiency as these vitamins (A, D, E and K) are co-absorbed with fat. Thus, some cystic fibrosis centres routinely administer these vitamins as supplements but the centres vary in their approach of addressing the possible development of deficiencies in these vitamins. Vitamin A deficiency causes predominantly eye and skin problems while supplementation of vitamin A to excessive levels may cause harm to the respiratory and skeletal systems in children. Thus a systematic review on vitamin A supplementation in people with cystic fibrosis would help guide clinical practice.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 27%
Student > Master 6 20%
Student > Bachelor 4 13%
Professor 2 7%
Student > Ph. D. Student 2 7%
Other 3 10%
Unknown 5 17%
Readers by discipline Count As %
Medicine and Dentistry 14 47%
Nursing and Health Professions 3 10%
Immunology and Microbiology 2 7%
Agricultural and Biological Sciences 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 10%
Unknown 5 17%